glp 1 clinical trials recruiting GLP-1a: Going beyond Traditional Use Enrollment of Females in Randomized

Safe discontinuation requires GP consultation to assess diabetes control, arrange monitoring, and establish alternative treatment if needed

Naltrexone is designed exactly for this situation

How does this GLP-1 supplement assist with appetite and craving control

Of note, in people with advanced DKD, additional glucose-lowering beyond SGLT2 inhibition will be necessary, making GLP-1 receptor agonists valuable drugs in this population

Only 34% of GLP-1 patients on DPP-4 inhibitors, a class of oral diabetic medications also known as gliptins, were still taking DPP-4 inhibitors 52 weeks after starting GLP-1 therapy according to Earnest pharmacy claims data

doi: 10.1016/S0140-6736(24)00469-0